146 related articles for article (PubMed ID: 21172961)
1. The role of somatostatin analogues in the treatment of advanced malignant thymomas: case report and review of the literature.
Pettit L; El-Modir A
Br J Radiol; 2011 Jan; 84(997):e7-e10. PubMed ID: 21172961
[TBL] [Abstract][Full Text] [Related]
2. Polymyositis with respiratory muscle weakness requiring mechanical ventilation in a patient with metastatic thymoma treated with octreotide.
Rini BI; Gajewski TF
Ann Oncol; 1999 Aug; 10(8):973-9. PubMed ID: 10509161
[TBL] [Abstract][Full Text] [Related]
3. Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone.
Ito J; Sekiya M; Miura K; Yoshimi K; Suzuki T; Seyama K; Izumi H; Uekusa T; Takahashi K
Intern Med; 2009; 48(12):1061-4. PubMed ID: 19525599
[TBL] [Abstract][Full Text] [Related]
4. Role of somatostatin analogue-based therapy in unresponsive malignant thymomas.
Palmieri G; Lastoria S; Montella L; Martignetti A; Lombardi G; Salvatore M; Bianco AR
Ann Med; 1999 Oct; 31 Suppl 2():80-5. PubMed ID: 10574161
[TBL] [Abstract][Full Text] [Related]
5. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.
Loehrer PJ; Jiroutek M; Aisner S; Aisner J; Green M; Thomas CR; Livingston R; Johnson DH
Cancer; 2001 Jun; 91(11):2010-5. PubMed ID: 11391579
[TBL] [Abstract][Full Text] [Related]
6. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.
Loehrer PJ; Wang W; Johnson DH; Aisner SC; Ettinger DS;
J Clin Oncol; 2004 Jan; 22(2):293-9. PubMed ID: 14722038
[TBL] [Abstract][Full Text] [Related]
7. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience.
Grassin F; Paleiron N; André M; Caliandro R; Bretel JJ; Terrier P; Margery J; Le Chevalier T; Ruffié P
J Thorac Oncol; 2010 Jun; 5(6):893-7. PubMed ID: 20521356
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy of malignant thymoma. Case report and review of the literature.
Hu E; Levine J
Cancer; 1986 Mar; 57(6):1101-4. PubMed ID: 3080220
[TBL] [Abstract][Full Text] [Related]
9. Regression of invasive thymoma following corticosteroid therapy.
Termeer A; Visser FJ; Mravunac M
Neth J Med; 2001 Apr; 58(4):181-4. PubMed ID: 11325496
[TBL] [Abstract][Full Text] [Related]
10. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Giaccone G; Ardizzoni A; Kirkpatrick A; Clerico M; Sahmoud T; van Zandwijk N
J Clin Oncol; 1996 Mar; 14(3):814-20. PubMed ID: 8622029
[TBL] [Abstract][Full Text] [Related]
11. Advanced pediatric inoperable thymus carcinoma (type C thymoma): case report on a novel therapeutic approach.
Kertesz GP; Hauser P; Varga P; Dabasi G; Schuler D; Garami M
J Pediatr Hematol Oncol; 2007 Nov; 29(11):774-5. PubMed ID: 17984697
[TBL] [Abstract][Full Text] [Related]
12. [Thymoma and somatostatin analogs. Biology, diagnostic and clinical practice].
Palmieri G; Montella L; Lastoria S
Minerva Endocrinol; 2001 Sep; 26(3):193-5. PubMed ID: 11753243
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of a patient with a thymoma and pure red-cell aplasia with octreotide and prednisone.
Palmieri G; Lastoria S; Colao A; Vergara E; Varrella P; Biondi E; Selleri C; Catalano L; Lombardi G; Bianco AR; Salvatore M
N Engl J Med; 1997 Jan; 336(4):263-5. PubMed ID: 8995089
[No Abstract] [Full Text] [Related]
14. Intensive chemotherapy with cisplatin, doxorubicin, cyclophosphamide, etoposide and granulocyte colony-stimulating factor for advanced thymoma or thymic cancer: preliminary results.
Oshita F; Kasai T; Kurata T; Fukuda M; Yamamoto N; Ohe Y; Tamura T; Eguchi K; Shinkai T; Saijo N
Jpn J Clin Oncol; 1995 Oct; 25(5):208-12. PubMed ID: 7474409
[TBL] [Abstract][Full Text] [Related]
15. The efficacy of combination cisplatinum, adriamycin and cyclophosphamide in malignant thymoma.
Shiu W; Teo P; Wong K
Br J Clin Pract; 1990 Nov; 44(11):519-20. PubMed ID: 2282317
[No Abstract] [Full Text] [Related]
16. Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases.
Giaccone G; Musella R; Bertetto O; Donadio M; Calciati A
Cancer Treat Rep; 1985 Jun; 69(6):695-7. PubMed ID: 4040423
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatment of malignant thymoma: a decade experience at a single institution.
Giaccone G; Wilmink H; Paul MA; van der Valk P
Am J Clin Oncol; 2006 Aug; 29(4):336-44. PubMed ID: 16891859
[TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptor scintigraphy and somatostatin therapy in the evaluation and treatment of malignant thymoma.
Lin K; Nguyen BD; Ettinger DS; Chin BB
Clin Nucl Med; 1999 Jan; 24(1):24-8. PubMed ID: 9890489
[TBL] [Abstract][Full Text] [Related]
19. Systemic treatments for thymoma and thymic carcinoma: A systematic review.
Berghmans T; Durieux V; Holbrechts S; Jungels C; Lafitte JJ; Meert AP; Moretti L; Ocak S; Roelandts M; Girard N
Lung Cancer; 2018 Dec; 126():25-31. PubMed ID: 30527189
[TBL] [Abstract][Full Text] [Related]
20. [A giant invasive thymoma made resectable by cisplatin + vincristine + doxorubicin + etoposide (CODE)].
Hosokawa T; Maki H; Saito T; Harada M; Isobe H
Gan To Kagaku Ryoho; 1999 Apr; 26(5):697-701. PubMed ID: 10234303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
